Neuroimaging of Movement Disorders (NiMoDis)

The Neuroimaging of Movement Disorders (NiMoDis) group is headed by Prof. Hartwig Siebner and Associate Professor Annemette Løkkegaard. 

The Neuroimaging of Movement Disorders (NiMoDis) group is headed by Prof. Hartwig Siebner and Associate Professor Annemette Løkkegaard. The NiMoDis group is situated both at DRCMR and the Department of Neurology at Copenhagen University Hospital Bispebjerg. Our research primarily focuses on Parkinson´s disease and dystonia. 

The mission of the NiMoDis group is to use advanced brain mapping techniques to investigate how movement disorders alter brain function and structure in motor, cognitive and limbic systems. We are not only interested in studying primary dysfunction directly caused by the movement disorder but also secondary dysfunctions of brain networks that are associated with therapy. We wish to exploit this knowledge to advance personalized medicine and precision treatment. 

Key projects

Tracing the emergence of dyskinesia in Parkinson´s disease

Dopamine replacement therapy with levodopa is a cornerstone in the treatment for Parkinson’s disease. While dopamine replacement therapy is effective, a large subgroup of patients develops involuntary movements (dyskinesia) as a side effect after several years of treatment. Our research group has recently implicated the pre-supplementary motor area (pre-SMA) in the pathophysiology of levodopa-induced dyskinesia. Using functional magnetic resonance imaging (fMRI), which reflects regional cerebral activity, we showed that a single oral dose of levodopa gave rise to an abnormal activation of the pre-SMA and the putamen during a response inhibition (NoGo) task in PD patients who would later develop dyskinesia. This hyperactivity emerged rapidly within a few minutes after the intake of levodopa. At the individual level, the excessive neural activation during the pre-dyskinesia period predicted the severity of patient´s day-to-day dyskinetic movements. This is the first time that a non-invasive neuroimaging technique was able to show a hypersensitization of key components of the motor network to levodopa in patients with dyskinesia. We are currently exploring this excessive network response in more detail.   

md Brain Cover

Fig. 1: Tracing the emergence of dyskinesia in Parkinson´s disease. Patients had to press a button on a compute mouse (Right or Left) or refrain from a response (NoGo) after dopamine withdrawal (OFF) and immediately after levodopa intake (ON), whilst functional MRI was simultaneously acquired. Functional MRI (fMRI) of the brain started shortly after levodopa intake and was stopped, as soon as dyskinesia emerged. Analysis of the fMRI data showed overactivity of the preSMA and putamen in patients who later developed dyskinesias. This difference in brain activity was only observed when patients had to withhold a movement (NoGo). Furthermore, the extent of the abnormal brain response to levodopa predicted whether or not a patient would develop dyskinesia and  correlated with the severity of levo-dopa induced dyskinesia.

Medication-induced impulse control disorders in Parkinson's disease

Over the recent years it has become evident that a substantial fraction of patients with Parkinson's disease develop impulse control disorders (ICD) as a result of dopaminergic medication. Most common ICD manifestations in Parkinson's disease are pathological gambling, compulsive buying, compulsive sexual behaviours and eating disorders. These impulsive behaviours have serious psycho-social and economic consequences for the patients and their relatives. It is widely thought that impulsive behaviours result from a dysfunction of brain networks involved in response inhibition.  

Using a novel sequential gambling paradigm for fMRI (see figure), we studied task-induced activation of the response inhibition networks in patients with and without ICD. On two separate days, we scanned patients with Parkinson´s disease, while they were taking their usual dopaminergic treatment and after treatment had been paused. This allowed us to investigate how response inhibition networks were affected by dopaminergic treatment in the two groups.

md dice

Fig. 2: Changes in inhibition networks in ICD. Patients with Parkinson´s Disease (PD) played a sequential dice gambling task.  In each round, patients accumulated reward in proportion to the number of eyes on the dice from throw to throw. If patients threw a “1”, all earnings accumulated in that round would be lost.  At each throw patients had the choice between continuing the gamble (CONTINUE) or to stop. 

Research Funding

We wish to thank for the generous support by the Danish Parkinson Association, Augustinusfonden, the Jascha Foundation, and the Danish Council for Independent Research - Health and Disease (grant. 09-072163) and Social Sciences (“Ludomaniprogrammet”, grant. 10-088255).

Selected Publications

Thomsen, B. L. C., Herz, D. M., Siebner, H. R. & Løkkegaard, A.
Dyskinesier ved Parkinsons sygdom: opdatering om nye billeddannende metoder og behandlingsmuligheder.
Ugeskrift for Laeger. 12, 2017, p. 2-6, 2017.

Lehéricy, S., Vaillancourt, D. E., Seppi, K., Monchi, O., Rektorova, I., Antonini, A., McKeown, M. J., Masellis, M., Berg, D., Rowe, J. B., Lewis, S. J. G., Williams-Gray, C. H., Tessitore, A., Siebner, H. R. & International Parkinson and Movement Disorder Society -Neuroimaging Study Group.
The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.
Movement disorders. 32, 4, p. 510-525, 2017.

Løkkegaard A, Herz DM, Haagensen BN, Lorentzen AK, Eickhoff SB, Siebner HR (2016) Altered sensorimotor activation patterns in idiopathic dystonia - an activation likelihood estimation meta-analysis of functional brain imaging studies. Hum Brain Mapp 37:547-557.

Herz DM,  Haagensen BN, Nielsen SH, Madsen KH, Løkkegaard A, Siebner HR (2016) Resting-state connectivity predicts levodopa-induced dyskinesias in Parkinson’s disease. Mov Disord 31:521-529.

Herz DM, Haagensen BN, Christensen MS, Madsen KH, Rowe JB, Løkkegaard A, Siebner HR (2015) Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans. Brain 138:1658-1666.

Herz DM, Haagensen BN,Christensen MS, Madsen KH, Rowe J, Løkkegaard A, Siebner HR (2014) The acute brain response to levodopa heralds dyskinesias in Parkinson’s disease. Ann Neurol 75:829-836.

Herz DM, Eickhoff SB, Løkkegaard A, Siebner HR (2014) Functional neuroimaging of motor control in Parkinson’s disease: A meta-analysis. Hum Brain Mapp 35:3227-3237. 

van der Vegt JPM, Hulme OJ, Zittel S, Madsen KH, Weiss MM, Buhmann C, Bloem BR, Münchau A, Siebner HR (2013) Attenuated neural response to gamble outcomes in drug-naive patients with Parkinson’s disease. Brain 136:1192-1203.



Group Members

Hartwig R. Siebner

Group Leader

David Meder

Christopher Fugl Madelung

Anders Elkjær Lund

Show all group members (7)

External Collaborators

Assoc. Prof. Annemette Løkkegaard

Copenhagen University Hospital Bispebjerg

Damian M. Herz, MD, PhD

Nuffield Department of Clinical Neurosciences
University of Oxford

Prof. Stéphane Lehericy, MD, PhD

Institut du Cerveau et de la Moelle épinière – ICM, 
Centre de NeuroImagerie de Recherche – CENIR, Sorbonne Universités, Paris

Prof. Angelo Quartarone, MD

Dept. of Neurosciences, Psychiatry and Anaesthesiological Sciences
University of Messina

Prof. James Rowe, MD, PhD

Behavioural and Clinical Neuroscience Institute
Dept. of Clinical Neurosciences, University of Cambridge.